For patients undergoing percutaneous coronary intervention (PCI), tailoring antiplatelet therapy based on the results of platelet function testing makes no difference in the risk of recurrent ischemic ...

In patients undergoing percutaneous coronary intervention (PCI), intensifying antiplatelet therapy based on platelet reactivity testing reduces cardiovascular mortality and stent thrombosis, according ...

The platelet-function analyzer is a high-shear system for in vitro testing of platelet function that simulates primary hemostasis after injury to a small vessel.

Two new studies suggest benefits for measuring platelet function in PCI patients. But not everyone agrees this is ready for routine use yet.

Study examines platelet function testing for guiding antithrombotic treatment before PCI procedures Date: September 20, 2011 Source: JAMA and Archives Journals Summary: Among patients with acute ...

Results from studies addressing the role of tailored therapy in patients identified as poor responders to conventional therapy by platelet function analysis such as GRAVITAS, TRIGGER-PCI, RESPOND ...

Material for platelet function analysis on the Multiplate device was provided free by Dynabyte.Sibbing received speaker fees from Dynabyte. Disclosures for the coauthors are listed in the paper.

This test is unreliable and its use discouraged; it has largely been replaced by objective closure time assays such as the PFA-100 (Platelet Function Analyzer).

The global platelet function test market is projected to be valued at USD 1.38 billion in 2025 and is expected to reach USD 2.61 billion by 2035, registering a CAGR of 6.3% during the forecast period.

Aggredyne’s AggreGuide platform is an excellent model for in-vitro platelet aggregation, and it is versatile, with potential to expand beyond platelet function testing to a full array of ...